Marcusso Rosa Maria N, Van Weyenbergh Johan, de Moura João Victor Luisi, Dahy Flávia Esper, de Moura Brasil Matos Aline, Haziot Michel E J, Vidal Jose E, Fonseca Luiz Augusto M, Smid Jerusa, Assone Tatiane, Casseb Jorge, de Oliveira Augusto César Penalva
Institute of Infectious Diseases "Emilio Ribas" (IIER) of São Paulo, São Paulo 01246-000, Brazil.
Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, 3000 Leuven, Belgium.
Pathogens. 2019 Dec 26;9(1):25. doi: 10.3390/pathogens9010025.
Despite its relatively low incidence of associated diseases, Human T-cell Leukemia Virus-1 (HTLV-1) infection was reported to carry a significant risk of mortality in several endemic areas. HTLV-1-associated diseases, adult T-cell leukemia/lymphoma (ATLL) and HTLV-1-associated myelopathy/tropical spastic paraperesis (HAM/TSP), as well as frequent coinfections with human immunodeficiency virus (HIV), hepatitis C virus (HCV), and were associated to increased morbidity and mortality of HTLV-1 infection. To determine the mortality rate and its associated variables from an open cohort started in July 1997 at the HTLV Clinic, Emilio Ribas Institute (IIER), a major infectious disease hospital in São Paulo, Brazil. Since inception up to September 2018, we admitted 727 HTLV-1-infected individuals, with a rate of 30-50 new admissions per year. All patient data, including clinical and laboratory data, were regularly updated throughout the 21-year period, using a dedicated REDCap database. The Ethical Board of IIER approved the protocol. During 21 years of clinical care to people living with HTLV-1 in the São Paulo region, we recruited 479 asymptomatic HTLV-1-infected individuals and 248 HAM/TSP patients, of which 632 remained under active follow-up. During a total of 3800 person-years of follow-up (maximum follow-up 21.5 years, mean follow-up 6.0 years), 27 individuals died (median age of 51.5 years), of which 12 were asymptomatic, one ATLL patient and 14 HAM/TSP patients. HAM/TSP diagnosis (but neither age nor gender) was a significant predictor of increased mortality by univariate and multivariate (hazard ratio (HR) 5.03, 95% CI [1.96-12.91], = 0.001) Cox regression models. Coinfection with HIV/HCV was an independent predictor of increased mortality (HR 15.08; 95% CI [5.50-41.32]; < 0.001), with AIDS-related infections as a more frequent cause of death in asymptomatics (6/13; = 0.033). HIV/HCV-negative fatal HAM/TSP cases were all female, with urinary tract infection and decubitus ulcer-associated sepsis as the main cause of death (8/14, = 0.002). All-cause mortality among people living with HTLV-1 in São Paulo differs between asymptomatic (2.9%) and HAM/TSP patients (7.3%), independent of age and gender. We observe a dichotomy in fatal cases, with HAM/TSP and HIV/HCV coinfection as independent risk factors for death. Our findings reveal an urgent need for public health actions, as the major causes of death, infections secondary to decubitus ulcers, and immune deficiency syndrome (AIDS)-related infections, can be targeted by preventive measures.
尽管人类T细胞白血病病毒1型(HTLV-1)感染相关疾病的发病率相对较低,但据报道,在几个流行地区,HTLV-1感染具有显著的死亡风险。HTLV-1相关疾病、成人T细胞白血病/淋巴瘤(ATLL)和HTLV-1相关脊髓病/热带痉挛性截瘫(HAM/TSP),以及与人类免疫缺陷病毒(HIV)、丙型肝炎病毒(HCV)的频繁合并感染,都与HTLV-1感染发病率和死亡率的增加有关。为了确定1997年7月在巴西圣保罗一家主要传染病医院埃米利奥·里巴斯研究所(IIER)的HTLV诊所启动的一个开放队列中的死亡率及其相关变量。从开始到2018年9月,我们收治了727例HTLV-1感染患者,每年新入院率为30 - 50例。在这21年期间,使用专用的REDCap数据库定期更新所有患者数据,包括临床和实验室数据。IIER伦理委员会批准了该方案。在圣保罗地区为HTLV-1感染者提供21年临床护理期间,我们招募了479例无症状HTLV-1感染个体和248例HAM/TSP患者,其中632例仍在接受积极随访。在总共3800人年的随访期间(最长随访21.5年,平均随访6.0年),27人死亡(中位年龄51.5岁),其中12例无症状,1例ATLL患者和14例HAM/TSP患者。单因素和多因素(风险比(HR)5.03,95%可信区间[1.96 - 12.91],P = 0.001)Cox回归模型显示,HAM/TSP诊断(但不是年龄和性别)是死亡率增加的显著预测因素。HIV/HCV合并感染是死亡率增加的独立预测因素(HR 15.08;95%可信区间[5.50 - 41.32];P < 0.001),艾滋病相关感染是无症状感染者更常见的死亡原因(6/13;P = 0.033)。HIV/HCV阴性的致命HAM/TSP病例均为女性,主要死亡原因是尿路感染和褥疮溃疡相关败血症(8/14,P = 0.002)。圣保罗HTLV-1感染者的全因死亡率在无症状感染者(2.9%)和HAM/TSP患者(7.3%)之间存在差异,与年龄和性别无关。我们在致命病例中观察到一种二分法,HAM/TSP和HIV/HCV合并感染是死亡的独立危险因素。我们的研究结果表明迫切需要采取公共卫生行动,因为主要死亡原因,即褥疮溃疡继发感染和免疫缺陷综合征(AIDS)相关感染,可以通过预防措施加以应对。